Table 1 Baseline Characteristics of Patients with DME Included in Two Treatment Groups
Characteristic | IVC Group | IVR Group | P value |
|---|---|---|---|
Number of patients, n | 32 | 30 | — |
Number of eyes, n | 36 | 32 | — |
Mean age ± SD (years) | 61.3 ± 14.9 | 60.7 ± 11.4 | 0.880* |
Gender, n (%) | |||
Men | 18(56.3) | 16(53.3) | |
Women | 14(43.7) | 14(46.7) | 0.818** |
Diabetes type, n (%) | |||
Type I | 3(9.4) | 2(6.7) | |
Type II | 29(90.6) | 28(93.3) | — |
DME type, n (%) | |||
Focal | 12(33.3) | 9(28.1) | |
Diffuse | 24(66.7) | 23(71.9) | 0.643** |
mean HbA1c ± SD | 7.9 ± 1.0 | 7.8 ± 0.8 | 0.904* |
Mean duration of diabetes ± SD (years) | 14.4 ± 6.8 | 13.2 ± 3.6 | 0.372* |
Mean duration of DME ± SD (months) | 4.2 ± 3.7 | 4.4 ± 3.0 | 0.847* |
Mean BCVA ± SD (letter score) | 49.4 ± 10.3 | 46.6 ± 10.9 | 0.272* |
Mean CRT ± SD (μm) | 469.3 ± 107.7 | 473.9 ± 100.6 | 0.858* |